Sales of devices slowed earlier this year because many elective hip and knee procedures were being postponed in the face of lost insurance coverage, high out-of-pocket charges or inability to take time off from work.
However, recent quarterly reports from Zimmer Holdings, Stryker Corp. and Johnson & Johnson have shown a modest improvement in sales.
Read Dow Jones Newswires’ report on the joint replacement market.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
